Literature DB >> 31397629

Characterization of Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Al Thawra University Hospital, Sana'a, Yemen.

Sameer Ahmed Alsharapy1,2, Alima Gharout-Sait1, Anaelle Muggeo3,4, Thomas Guillard3,4, Pascal Cholley5,6, Lucien Brasme3,4, Xavier Bertrand5,6, Ghuzlan Saeed Moghram2, Abdelaziz Touati1, Christophe De Champs3,4.   

Abstract

Objective: The aim of this study was to investigate the resistance mechanisms of carbapenem-resistant Enterobacteriaceae clinical strains recovered from Al Thawra University Hospital, Sana'a, Yemen.
Methods: A total of 27 isolates showing decreased susceptibility to carbapenems were obtained from different clinical specimens in Al Thawra Hospital, Sana'a, Yemen. Strains were identified by Matrix Assisted Laser Desorption Ionization Time-Of-Flight spectroscopy. Susceptibility to antibiotics was determined by the disk diffusion method on Mueller Hinton agar. Carbapenemases-encoding genes, extended-spectrum β-lactamases (ESBLs), and plasmid-mediated quinolone resistance (PMQR) genes were screened by PCR. Bacterial isolates were typed by multilocus sequence typing (MLST).
Results: Carbapenemase genes detection and sequencing showed that 18 (66.7%) isolates were Klebsiella pneumoniae (NDM-1, n = 13; NDM-1 + OXA-48, n = 3; OXA-48, n = 1; OXA-232, n = 1), 6 (22.2%) were Escherichia coli (NDM-5, n = 3; OXA-181, n = 2; OXA-48, n = 1), and 3 (11.1%) were Enterobacter cloacae (NDM-1, n = 1; OXA-181, n = 2). In addition the ESBL gene blaCTX-M-15 was detected in 14 K. pneumoniae and 2 E. coli isolates, and the blaCTX-M-216 was found in 1 E. coli isolate. Fifteen isolates were PMQR positive including qnrB1 (n = 1), qnrS1 (n = 5), qnrS4 (n = 2), and aac-(6')-Ib-cr (n = 7). The MLST typing showed a diversity of sequence type (ST) clones including Escherichia coli ST410 (3), ST448 (2), and ST648; Enterobacter cloacae ST78 and ST270; and Klebsiella pneumoniae ST395 (2), ST309, ST23, ST35, ST1728, ST15, ST231, and ST1428.
Conclusion: This study reports the first description of OXA-48-like-producing Enterobacteriaceae and NDM-5 enzymes in E. coli in Yemen.

Entities:  

Keywords:  Enterobacteriaceae; NDM-1-like; OXA-48-like; Yemen; carbapenemases

Year:  2019        PMID: 31397629     DOI: 10.1089/mdr.2018.0443

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  5 in total

1.  Emergence of an NDM-5-Producing Hypervirulent Klebsiella pneumoniae Sequence Type 35 Strain with Chromosomal Integration of an Integrative and Conjugative Element, ICEKp1.

Authors:  Zhen Shen; Qianqian Gao; Juanxiu Qin; Yao Liu; Min Li
Journal:  Antimicrob Agents Chemother       Date:  2019-12-20       Impact factor: 5.191

2.  Third Generation Cephalosporin Resistant Enterobacterales Infections in Hospitalized Horses and Donkeys: A Case-Case-Control Analysis.

Authors:  Anat Shnaiderman-Torban; Dror Marchaim; Shiri Navon-Venezia; Ori Lubrani; Yossi Paitan; Haya Arielly; Amir Steinman
Journal:  Antibiotics (Basel)       Date:  2021-02-04

3.  Microbial Resistance to Carbapenems in Effluents from Gynaecological, Paediatric and Surgical Hospital Units.

Authors:  El Hassan Loumame; Abdessamad Tounsi; Soumia Amir; Nabila Soraa; Naaila Ouazzani
Journal:  Antibiotics (Basel)       Date:  2022-08-15

4.  High Prevalence of CTX-M Type Extended-Spectrum Beta-Lactamase Genes and Detection of NDM-1 Carbapenemase Gene in Extraintestinal Pathogenic Escherichia coli in Cuba.

Authors:  Dianelys Quiñones; Meiji Soe Aung; Yenisel Carmona; María Karla González; Niurka Pereda; Mercedes Hidalgo; Mayrelis Rivero; Arnaldo Zayas; Rosa Del Campo; Noriko Urushibara; Nobumichi Kobayashi
Journal:  Pathogens       Date:  2020-01-16

5.  Klebsiella pneumoniae Complex Harboring mcr-1, mcr-7, and mcr-8 Isolates from Slaughtered Pigs in Thailand.

Authors:  Nattamol Phetburom; Parichart Boueroy; Peechanika Chopjitt; Rujirat Hatrongjit; Yukihiro Akeda; Shigeyuki Hamada; Suphachai Nuanualsuwan; Anusak Kerdsin
Journal:  Microorganisms       Date:  2021-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.